Diagnostics

There’s a whole new world of molecular diagnostics out there. Why has innovation been restricted?

RNA biomarkers lag behind DNA and proteins in clinical use because of the limitations of lab technology – but new analytical tools could now make RNA a useful tool in the pathologist’s kit

Research discoveries continue to improve the outlook, but how promising are they?

A new blood test could detect type 1 diabetes decades before symptoms develop

A new three-biomarker panel may allow early detection of the disease at a stage when curative surgical treatment may still be possible

Han van Krieken discusses the ways in which laboratory medicine is evolving, the difference between old and young pathologists, and the obstacles facing both of them today

A better understanding of melanoma could lead to new strategies for tackling therapy resistance

Current tests for nephropathy may not be good enough; but research could yield new options for effective diagnosis

Next generation sequencing holds much promise for personalized cancer diagnosis, treatment and management, but how is this being realized and what does the future hold?

As consumer genetic testing becomes cheaper and easier to access, medical professionals worry that unregulated Internet marketing may steer patients in the wrong direction